Emerging roles of spliceosome in cancer and immunity

Abstract

Precursor messenger RNA (pre-mRNA) splicing is catalyzed by an intricate ribonucleoprotein complex called the spliceosome. Although the spliceosome is considered to be general cell “housekeeping” machinery, mutations in core components of the spliceosome frequently correlate with cellor tissue-specific phenotypes and diseases. In this review, we expound the links between spliceosome mutations, aberrant splicing, and human cancers. Remarkably, spliceosome-targeted therapies (STTs) have become efficient anti-cancer strategies for cancer patients with splicing defects. We also highlight the links between spliceosome and immune signaling. Recent studies have shown that some spliceosome gene mutations can result in immune dysregulation and notable phenotypes due to missplicing of immune-related genes. Furthermore, several core spliceosome components harbor splicing-independent immune functions within the cell, expanding the functional repertoire of these diverse proteins.

Key words： spliceosome; splicing; cancer; innate immunity; immune dysregulation

References

1 Adler AS , McCleland ML, Yee S, Yaylaoglu M, Hussain S, Cosino E, Quinones G, Modrusan Z, Seshagiri S, Torres E ( 2014) An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth . Genes Dev 28: 1068– 1084

2 Albers CA, Paul DS, Schulze H, Freson K, Stephens JC, Smethurst PA, Jolley JD, Cvejic A, Kostadima M, Bertone P ( 2012) Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome . Nat Genet 44: 435– 439

3 Alsafadi S, Houy A, Battistella A, Popova T, Wassef M, Henry E, Tirode F, Constantinou A, Piperno-Neumann S, Roman-Roman S ( 2016) Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage . Nat Commun 7: 10615

4 Anczukow O, Krainer AR ( 2016) Splicing-factor alterations in cancers . RNA 22: 1285– 1301

5 Argente J, Flores R, Gutierrez-Arumi A, Verma B, Martos-Moreno GA, Cusco I, Oghabian A, Chowen JA, Frilander MJ, Perez-Jurado LA ( 2014) Defective minor spliceosome mRNA processing results in isolated familial growth hormone deficiency . EMBO Mol Med 6: 299– 306

6 Bacrot S, Doyard M, Huber C, Alibeu O, Feldhahn N, Lehalle D, Lacombe D, Marlin S, Nitschke P, Petit F ( 2015) Mutations in SNRPB, encoding components of the core splicing machinery, cause cerebro-costo-mandibular syndrome . Hum Mutat 36: 187– 190

7 Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJ, Quinn MC ( 2016) Genomic analyses identify molecular subtypes of pancreatic cancer . Nature 531: 47– 52

8 Baldridge MT, King KY, Goodell MA ( 2011) Inflammatory signals regulate hematopoietic stem cells . Trends Immunol 32: 57– 65

9 Bejar R, Stevenson KE, Caughey BA, Abdel-Wahab O, Steensma DP, Galili N, Raza A, Kantarjian H, Levine RL, Neuberg D ( 2012) Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes . J Clin Oncol 30: 3376– 3382

10 Bernier FP, Caluseriu O, Ng S, Schwartzentruber J, Buckingham KJ, Innes AM, Jabs EW, Innis JW, Schuette JL, Gorski JL ( 2012) Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome . Am J Hum Genet 90: 925– 933

11 Bersanelli M, Travaglino E, Meggendorfer M, Matteuzzi T, Sala C, Mosca E, Chiereghin C, Di Nanni N, Gnocchi M, Zampini M ( 2021) Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes . J Clin Oncol 39: 1223– 1233

12 Blaustein M, Pelisch F, Tanos T, Munoz MJ, Wengier D, Quadrana L, Sanford JR, Muschietti JP, Kornblihtt AR, Caceres JF ( 2005) Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT . Nat Struct Mol Biol 12: 1037– 1044

13 Boguslawska J, Sokol E, Rybicka B, Czubaty A, Rodzik K, Piekielko-Witkowska A ( 2016) microRNAs target SRSF7 splicing factor to modulate the expression of osteopontin splice variants in renal cancer cells . Gene 595: 142– 149

14 Bonnal SC, Lopez-Oreja I, Valcarcel J ( 2020) Roles and mecha-nisms of alternative splicing in cancer- implications for care . Nat Rev Clin Oncol 17: 457– 474

15 Bowling EA, Wang JH, Gong F, Wu W, Neill NJ, Kim IS, Tyagi S, Orellana M, Kurley SJ, Dominguez-Vidana R ( 2021) Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer . Cell 184: 384– 403

16 Brooks AN, Choi PS, de Waal L, Sharifnia T, Imielinski M, Saksena G, Pedamallu CS, Sivachenko A, Rosenberg M, Chmielecki J ( 2014) A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events . PLoS ONE 9: e87361

17 Burge CB, Padgett RA, Sharp PA ( 1998) Evolutionary fates and origins of U12-type introns . Mol Cell 2: 773– 785

18 Chakarova CF, Hims MM, Bolz H, Abu-Safieh L, Patel RJ, Papaioannou MG, Inglehearn CF, Keen TJ, Willis C, Moore AT ( 2002) Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa . Hum Mol Genet 11: 87– 92

19 Chen X, Liu Y, Sheng X, Tam PO, Zhao K, Chen X, Rong W, Liu Y, Liu X, Pan X ( 2014) PRPF4 mutations cause autosomal dominant retinitis pigmentosa . Hum Mol Genet 23: 2926– 2939

20 Corbett MA, Dudding-Byth T, Crock PA, Botta E, Christie LM, Nardo T, Caligiuri G, Hobson L, Boyle J, Mansour A ( 2015) A novel X-linked trichothiodystrophy associated with a nonsense mutation in RNF113A . J Med Genet 52: 269– 274

21 Corbo C, Orru S, Gemei M, Noto RD, Mirabelli P, Imperlini E, Ruoppolo M, Vecchio LD, Salvatore F ( 2012) Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity . Proteomics 12: 2045– 2059

22 Cvitkovic I, Jurica MS ( 2013) Spliceosome database: a tool for tracking components of the spliceosome . Nucleic Acids Res 41: D132– 141

23 Damm F, Kosmider O, Gelsi-Boyer V, Renneville A, Carbuccia N, Hidalgo-Curtis C, Della Valle V Couronne L, Scourzic L, Chesnais V, ( 2012) Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes . Blood 119: 3211– 3218

24 Darman RB, Seiler M, Agrawal AA, Lim KH, Peng S, Aird D, Bailey SL, Bhavsar EB, Chan B, Colla S ( 2015) Cancer-associated SF3B1 hotspot mutations induce Cryptic 3’ splice site selection through use of a different branch point . Cell Rep 13: 1033– 1045

25 Dauber A, Golzio C, Guenot C, Jodelka FM, Kibaek M, Kjaergaard S, Leheup B, Martinet D, Nowaczyk MJ, Rosenfeld JA ( 2013) SCRIB and PUF60 are primary drivers of the multisystemic phenotypes of the 8q24.3 copy-number variant . Am J Hum Genet 93: 798– 811

26 De Arras L, Alper S ( 2013) Limiting of the innate immune response by SF3A-dependent control of MyD88 alternative mRNA splicing . PLoS Genet 9: e1003855

27 De Arras L, Laws R, Leach SM, Pontis K, Freedman JH, Schwartz DA, Alper S ( 2014) Comparative genomics RNAi screen identifies Eftud2 as a novel regulator of innate immunity . Genetics 197: 485– 496

28 Deery EC, Vithana EN, Newbold RJ, Gallon VA, Bhattacharya SS, Warren MJ, Hunt DM, Wilkie SE ( 2002) Disease mechanism for retinitis pigmentosa (RP11) caused by mutations in the splicing factor gene PRPF31 . Hum Mol Genet 11: 3209– 3219

29 Desai P, Mencia-Trinchant N, Savenkov O, Simon MS, Cheang G, Lee S, Samuel M, Ritchie EK, Guzman ML, Ballman KV ( 2018) Somatic mutations precede acute myeloid leukemia years before diagnosis . Nat Med 24: 1015– 1023

30 Devotta A, Juraver-Geslin H, Gonzalez JA, Hong CS, Saint-Jeannet JP ( 2016) Sf3b4-depleted Xenopus embryos: A model to study the pathogenesis of craniofacial defects in Nager syndrome . Dev Biol 415: 371– 382

31 Dominski Z, Kole R ( 1993) Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides . Proc Natl Acad Sci U S A 90: 8673– 8677

32 Dvinge H, Kim E, Abdel-Wahab O, Bradley RK ( 2016) RNA splicing factors as oncoproteins and tumour suppressors . Nat Rev Cancer 16: 413– 430

33 Edery P, Marcaillou C, Sahbatou M, Labalme A, Chastang J, Touraine R, Tubacher E, Senni F, Bober MB, Nampoothiri S ( 2011) Association of TALS developmental disorder with defect in minor splicing component U4atac snRNA . Science 332: 240– 243

34 Elsaid MF, Chalhoub N, Ben-Omran T, Kumar P, Kamel H, Ibrahim K, Mohamoud Y, Al-Dous E, Al-Azwani I, Malek JA ( 2017) Mutation in noncoding RNA RNU12 causes early onset cerebel-lar ataxia . Ann Neurol 81: 68– 78

35 Eymin B ( 2021) Targeting the spliceosome machinery: A new therapeutic axis in cancer? Biochem Pharmacol 189: 114039

36 Fabrizio P, Dannenberg J, Dube P, Kastner B, Stark H, Urlaub H, Luhrmann R ( 2009) The evolutionarily conserved core design of the catalytic activation step of the yeast spliceosome . Mol Cell 36: 593– 608

37 Fallini C, Donlin-Asp PG, Rouanet JP, Bassell GJ, Rossoll W ( 2016) Deficiency of the survival of motor neuron protein impairs mrna localization and local translation in the growth cone of motor neurons . J Neurosci 36: 3811– 3820

38 Favaro FP, Alvizi L, Zechi-Ceide RM, Bertola D, Felix TM, de Souza J, Raskin S, Twigg SR, Weiner AM, Armas P ( 2014) A noncoding expansion in EIF4A3 causes Richieri-Costa-Pereira syndrome, a craniofacial disorder associated with limb defects . Am J Hum Genet 94: 120– 128

39 Folco EG, Coil KE, Reed R ( 2011) The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region . Genes Dev 25: 440– 444

40 Freund C, Kuhne R, Yang H, Park S, Reinherz EL, Wagner G ( 2002) Dynamic interaction of CD2 with the GYF and the SH3 domain of compartmentalized effector molecules . EMBO J 21: 5985– 5995

41 Furney SJ, Pedersen M, Gentien D, Dumont AG, Rapinat A, Desjardins L, Turajlic S, Piperno-Neumann S, de la Grange P, Roman-Roman S ( 2013) SF3B1 mutations are associated with alternative splicing in uveal melanoma . Cancer Discov 3: 1122– 1129

42 Goncalves V, Matos P, Jordan P ( 2008) The beta-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression . RNA 14: 2538– 2549

43 Graubert TA, Shen D, Ding L, Okeyo-Owuor T, Lunn CL, Shao J, Krysiak K, Harris CC, Koboldt DC, Larson DE ( 2011) Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes . Nat Genet 44: 53– 57

44 Grignano E, Jachiet V, Fenaux P, Ades L, Fain O, Mekinian A ( 2018) Autoimmune manifestations associated with myelodysplastic syndromes . Ann Hematol 97: 2015– 2023

45 Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T ( 2014) Landscape of genetic lesions in 944 patients with myelodysplas-tic syndromes . Leukemia 28: 241– 247

46 Harbour JW, Roberson ED, Anbunathan H, Onken MD, Worley LA, Bowcock AM ( 2013) Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma . Nat Genet 45: 133– 135

47 Havens MA, Hastings ML ( 2016) Splice-switching antisense oligonu-cleotides as therapeutic drugs . Nucleic Acids Res 44: 6549– 6563

48 He H, Liyanarachchi S, Akagi K, Nagy R, Li J, Dietrich RC, Li W, Sebastian N, Wen B, Xin B ( 2011) Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I . Science 332: 238– 240

49 Heaney ML, Golde DW ( 1999) Myelodysplasia . N Engl J Med 340: 1649– 1660

50 Heinze M, Kofler M, Freund C ( 2007) Investigating the functional role of CD2BP2 in T cells . Int Immunol 19: 1313– 1318

51 Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK ( 2015) U2AF1 mutations alter splice site recognition in hematological malignancies . Genome Res 25: 14– 26

52 Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M, Sivachenko A ( 2012) Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing . Cell 150: 1107– 1120

53 Inoue D, Bradley RK, Abdel-Wahab O ( 2016) Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis . Genes Dev 30: 989– 1001

54 Inoue D, Polaski JT, Taylor J, Castel P, Chen S, Kobayashi S, Hogg SJ, Hayashi Y, Pineda JMB, El Marabti E ( 2021) Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition . Nat Genet 53( 5): 707– 718

55 Ishak CA, Loo Yau H, De Carvalho DD ( 2021) Spliceosome-targeted therapies induce dsRNA responses . Immunity 54: 11– 13

56 Ishihara T, Ariizumi Y, Shiga A, Kato T, Tan CF, Sato T, Miki Y, Yokoo M, Fujino T, Koyama A ( 2013) Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis . Hum Mol Genet 22: 4136– 4147

57 Johnston JJ, Teer JK, Cherukuri PF, Hansen NF, Loftus SK, Center NIHIS, Chong K, Mullikin JC, Biesecker LG ( 2010) Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate . Am J Hum Genet 86: 743– 748

58 Jumaa H, Nielsen PJ ( 1997) The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation . EMBO J 16: 5077– 5085

59 Jurica MS, Moore MJ ( 2003) Pre-mRNA splicing: awash in a sea of proteins . Mol Cell 12: 5– 14

60 Kaida D, Motoyoshi H, Tashiro E, Nojima T, Hagiwara M, Ishigami K, Watanabe H, Kitahara T, Yoshida T, Nakajima H ( 2007) Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA . Nat Chem Biol 3: 576– 583

61 Kalscheuer VM, Freude K, Musante L, Jensen LR, Yntema HG, Gecz J, Sefiani A, Hoffmann K, Moser B, Haas S ( 2003) Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation . Nat Genet 35: 313– 315

62 Katsuyama T, Li H, Krishfield SM, Kyttaris VC, Moulton VR ( 2021) Splicing factor SRSF1 limits IFN-gamma production via RhoH and ameliorates experimental nephritis . Rheumatology (oxford) 60: 420– 429

63 Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC, Ramakrishnan A, Li Y, Chung YR, Micol JB, Murphy ME ( 2015) SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition . Cancer Cell 27: 617– 630

64 Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A ( 2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multi-system proteinopathy and ALS . Nature 495: 467– 473

65 Kofler M, Heuer K, Zech T, Freund C ( 2004) Recognition sequences for the GYF domain reveal a possible spliceosomal function of CD2BP2 . J Biol Chem 279: 28292– 28297

66 Koh CM, Bezzi M, Low DH, Ang WX, Teo SX, Gay FP, Al-Haddawi M, Tan SY, Osato M, Sabo A ( 2015) MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis . Nature 523: 96– 100

67 Koizumi J, Okamoto Y, Onogi H, Mayeda A, Krainer AR, Hagiwara M ( 1999) The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs) . J Biol Chem 274: 11125– 11131

68 Komeno Y, Huang YJ, Qiu J, Lin L, Xu Y, Zhou Y, Chen L, Monterroza DD, Li H, DeKelver RC ( 2015) SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing . Mol Cell Biol 35: 3071– 3082

69 Kong J, Sun W, Li C, Wan L, Wang S, Wu Y, Xu E, Zhang H, Lai M ( 2016) Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6 . Cancer Lett 380: 476– 484

70 Kotake Y, Sagane K, Owa T, Mimori-Kiyosue Y, Shimizu H, Uesugi M, Ishihama Y, Iwata M, Mizui Y ( 2007) Splicing factor SF3b as a target of the antitumor natural product pladienolide . Nat Chem Biol 3: 570– 575

71 Kurtovic-Kozaric A, Przychodzen B, Singh J, Konarska MM, Clemente MJ, Otrock ZK, Nakashima M, Hsi ED, Yoshida K, Shiraishi Y ( 2015) PRPF8 defects cause missplicing in myeloid malignancies . Leukemia 29: 126– 136

72 Laggerbauer B, Liu S, Makarov E, Vornlocher HP, Makarova O, Ingelfinger D, Achsel T, Luhrmann R ( 2005) The human U5 snRNP 52K protein (CD2BP2) interacts with U5–102K (hPrp6), a U4/U6.U5 tri-snRNP bridging protein, but dissociates upon tri-snRNP formation . RNA 11: 598– 608

73 Lai MC, Lin RI, Huang SY, Tsai CW, Tarn WY ( 2000) A human importin-beta family protein, transportin-SR2, interacts with the phosphorylated RS domain of SR proteins . J Biol Chem 275: 7950– 7957

74 Lee SC, Abdel-Wahab O ( 2016) Therapeutic targeting of splicing in cancer . Nat Med 22: 976– 986

75 Lee SC, North K, Kim E, Jang E, Obeng E, Lu SX, Liu B, Inoue D, Yoshimi A, Ki M ( 2018) Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene muta-tions . Cancer Cell 34: 225– 241

76 Li DK, Tisdale S, Lotti F, Pellizzoni L ( 2014) SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease . Semin Cell Dev Biol 32: 22– 29

77 Li YI, van de Geijn B, Raj A, Knowles DA, Petti AA, Golan D, Gilad Y, Pritchard JK ( 2016) RNA splicing is a primary link between genetic variation and disease . Science 352: 600– 604

78 Lindsley RC, Mar BG, Mazzola E, Grauman PV, Shareef S, Allen SL, Pigneux A, Wetzler M, Stuart RK, Erba HP ( 2015) Acute myeloid leukemia ontogeny is defined by distinct somatic mutations . Blood 125: 1367– 1376

79 Lines MA, Huang L, Schwartzentruber J, Douglas SL, Lynch DC, Beaulieu C, Guion-Almeida ML, Zechi-Ceide RM, Gener B, Gillessen-Kaesbach G ( 2012) Haploinsufficiency of a spliceosomal GTPase encoded by EFTUD2 causes mandibulofacial dysostosis with microcephaly . Am J Hum Genet 90: 369– 377

80 Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, Du F, Ren J, Wu YT, Grishin NV ( 2015) Phosphorylation of innate immune-adaptor proteins MAVS, STING, and TRIF induces IRF3 activa-tion . Science 347: aaa2630

81 Liu T, Jin X, Zhang X, Yuan H, Cheng J, Lee J, Zhang B, Zhang M, Wu J, Wang L ( 2012) A novel missense SNRNP200 mutation associated with autosomal dominant retinitis pigmen-tosa in a Chinese family . PLoS ONE 7: e45464

82 Low KJ, Ansari M, Abou Jamra R, Clarke A, El Chehadeh S FitzPatrick DR, Greenslade M, Henderson A, Hurst J, Keller K, ( 2017) PUF60 variants cause a syndrome of ID, short stature, microcephaly, coloboma, craniofacial, cardiac, renal and spinal features . Eur J Hum Genet 25: 552– 559

83 Lv Z, Wang Z, Luo L, Chen Y, Han G, Wang R, Xiao H, Li X, Hou C, Feng J ( 2019) Spliceosome protein Eftud2 promotes colitis-associated tumorigenesis by modulating inflammatory response of macrophage . Mucosal Immunol 12: 1164– 1173

84 Lynch DC, Revil T, Schwartzentruber J, Bhoj EJ, Innes AM, Lamont RE, Lemire EG, Chodirker BN, Taylor JP, Zackai EH ( 2014) Disrupted auto-regulation of the spliceosomal gene SNRPB causes cerebro-costo-mandibular syndrome . Nat Commun 5: 4483

85 Madan V, Kanojia D, Li J, Okamoto R, Sato-Otsubo A, Kohlmann A, Sanada M, Grossmann V, Sundaresan J, Shiraishi Y ( 2015) Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome . Nat Commun 6: 6042

86 Maguire SL, Leonidou A, Wai P, Marchio C, Ng CK, Sapino A, Salomon AV, Reis-Filho JS, Weigelt B, Natrajan RC ( 2015) SF3B1 mutations constitute a novel therapeutic target in breast cancer . J Pathol 235: 571– 580

87 Malcovati L, Karimi M, Papaemmanuil E, Ambaglio I, Jadersten M, Jansson M, Elena C, Galli A, Walldin G, Della Porta MG ( 2015) SF3B1 mutation identifies a distinct subset of myelodys-plastic syndrome with ring sideroblasts . Blood 126: 233– 241

88 Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C, Travaglino E, Groves MJ, Godfrey AL, Ambaglio I ( 2011) Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloprolifera-tive neoplasms . Blood 118: 6239– 6246

89 Marques F, Tenney J, Duran I, Martin J, Nevarez L, Pogue R, Krakow D, Cohn DH, Li B ( 2016) Altered mRNA splicing, chondrocyte gene expression and abnormal skeletal development due to SF3B4 mutations in rodriguez acrofacial dysostosis . PLoS Genet 12: 1006307

90 Martin M, Masshofer L, Temming P, Rahmann S, Metz C, Bornfeld N, van de Nes J, Klein-Hitpass L , Hinnebusch AG, Horsthemke B ( 2013) Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3 . Nat Genet 45: 933– 936

91 Matlin AJ, Moore MJ ( 2007) Spliceosome assembly and composi-tion . Adv Exp Med Biol 623: 14– 35

92 Maubaret CG, Vaclavik V, Mukhopadhyay R, Waseem NH, Churchill A, Holder GE, Moore AT, Bhattacharya SS, Webster AR ( 2011) Autosomal dominant retinitis pigmentosa with intrafamilial variability and incomplete penetrance in two families carrying mutations in PRPF8 . Invest Ophthalmol vis Sci 52: 9304– 9309

93 McKie AB, McHale JC, Keen TJ, Tarttelin EE, Goliath R, van Lith-Verhoeven JJ, Greenberg J, Ramesar RS, Hoyng CB, Cremers FP ( 2001) Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13) . Hum Mol Genet 10: 1555– 1562

94 Meggendorfer M, Roller A, Haferlach T, Eder C, Dicker F, Grossmann V, Kohlmann A, Alpermann T, Yoshida K, Ogawa S ( 2012) SRSF2 mutations in 275 cases with chronic myelomono-cytic leukemia (CMML) . Blood 120: 3080– 3088

95 Merico D, Roifman M, Braunschweig U, Yuen RK, Alexandrova R, Bates A, Reid B, Nalpathamkalam T, Wang Z, Thiruvahindrapuram B ( 2015) Compound heterozygous mutations in the noncoding RNU4ATAC cause Roifman Syndrome by disrupting minor intron splicing . Nat Commun 6: 8718

96 Meseguer S, Mudduluru G, Escamilla JM, Allgayer H, Barettino D ( 2011) MicroRNAs-10a and-10b contribute to retinoic acidinduced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF) . J Biol Chem 286: 4150– 4164

97 Moore MJ, Query CC, Sharp PA ( 1993) Splicing of precursors to mRNA by the spliceosome. In RNA World, Gesteland RF, Atkins JF, eds . (Cold Spring Harbor, New York, Cold Spring Harbor Labratory Press), pp. 303– 357

98 Nguyen HD, Leong WY, Li W, Reddy PNG, Sullivan JD, Walter MJ, Zou L, Graubert TA ( 2018) Spliceosome mutations induce R Loop-associated sensitivity to ATR inhibition in myelodysplastic syndromes . Cancer Res 78: 5363– 5374

99 Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC ( 2016) Landscape of somatic mutations in 560 breast cancer whole-genome sequences . Nature 534: 47– 54

100 Nilsen TW, Graveley BR ( 2010) Expansion of the eukaryotic proteome by alternative splicing . Nature 463: 457– 463

101 Nishanian TG, Waldman T ( 2004) Interaction of the BMPR-IA tumor suppressor with a developmentally relevant splicing factor . Biochem Biophys Res Commun 323: 91– 97

102 Nishizawa K, Freund C, Li J, Wagner G, Reinherz EL ( 1998) Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation . Proc Natl Acad Sci U S A 95: 14897– 14902

103 Novoyatleva T, Tang Y, Rafalska I, Stamm S ( 2006) Pre-mRNA missplicing as a cause of human disease . Prog Mol Subcell Biol 44: 27– 46

104 O’Connor BP, Danhorn T, De Arras L, Flatley BR, Marcus RA, Farias-Hesson E, Leach SM, Alper S ( 2015) Regulation of tolllike receptor signaling by the SF3a mRNA splicing complex . PLoS Genet 11: 1004932

105 Okeyo-Owuor T, White BS, Chatrikhi R, Mohan DR, Kim S, Griffith M, Ding L, Ketkar-Kulkarni S, Hundal J, Laird KM ( 2015) U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing . Leukemia 29: 909– 917

106 Pagano L, Caira M ( 2012) Risks for infection in patients with myelodysplasia and acute leukemia . Curr Opin Infect Dis 25: 612– 618

107 Paine I, Posey JE, Grochowski CM, Jhangiani SN, Rosenheck S, Kleyner R, Marmorale T, Yoon M, Wang K, Robison R ( 2019) Paralog Studies Augment Gene Discovery: DDX and DHX Genes . Am J Hum Genet 105: 302– 316

108 Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, Pellagatti A, Wainscoat JS, Hellstrom-Lindberg E, Gambacorti-Passerini C ( 2011) Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts . N Engl J Med 365: 1384– 1395

109 Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N ( 2016) Genomic classification and prognosis in acute myeloid leukemia . N Engl J Med 374: 2209– 2221

110 Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P Yoon CJ, Ellis P, Wedge DC, Pellagatti A, ( 2013) Clinical and biological implications of driver mutations in myelodysplastic syndromes . Blood 122: 3616– 3627

111 Pasternack SM, Refke M, Paknia E, Hennies HC, Franz T, Schafer N, Fryer A, van Steensel M Sweeney E, Just M, ( 2013) Mutations in SNRPE, which encodes a core protein of the spliceosome, cause autosomal-dominant hypotrichosis simplex . Am J Hum Genet 92: 81– 87

112 Patel AA, Steitz JA ( 2003) Splicing double: insights from the second spliceosome . Nat Rev Mol Cell Biol 4: 960– 970

113 Paz S, Ritchie A, Mauer C, Caputi M ( 2021) The RNA binding protein SRSF1 is a master switch of gene expression and regulation in the immune system . Cytokine Growth Factor Rev 57: 19– 26

114 Pellagatti A, Boultwood J ( 2015) The molecular pathogenesis of the myelodysplastic syndromes . Eur J Haematol 95: 3– 15

115 Petit F, Escande F, Jourdain AS, Porchet N, Amiel J, Doray B, Delrue MA, Flori E, Kim CA, Marlin S ( 2014) Nager syndrome: confirmation of SF3B4 haploinsufficiency as the major cause . Clin Genet 86: 246– 251

116 Pollyea DA, Harris C, Rabe JL, Hedin BR, De Arras L, Katz S, Wheeler E, Bejar R, Walter MJ, Jordan CT ( 2019) Myelodysplastic syndrome-associated spliceosome gene muta-tions enhance innate immune signaling . Haematologica 104: e388– e392

117 Polprasert C, Schulze I, Sekeres MA, Makishima H, Przychodzen B, Hosono N, Singh J, Padgett RA, Gu X, Phillips JG ( 2015) Inherited and somatic defects in DDX41 in myeloid neoplasms . Cancer Cell 27: 658– 670

118 Qi Z, Wang F, Yu G, Wang D, Yao Y, You M, Liu J, Liu J, Sun Z, Ji C ( 2021) SRSF1 serves as a critical posttranscriptional regulator at the late stage of thymocyte development . Sci Adv 7: eabf0753

119 Quemener AM, Bachelot L, Forestier A, Donnou-Fournet E, Gilot D, Galibert MD ( 2020) The powerful world of antisense oligonu-cleotides: From bench to bedside . Wiley Interdiscip Rev RNA 11: 1594

120 Quesada V, Conde L, Villamor N, Ordonez GR, Jares P, Bas-saganyas L, Ramsay AJ, Bea S, Pinyol M, Martinez-Trillos A ( 2011) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia . Nat Genet 44: 47– 52

121 Rahman MA, Krainer AR, Abdel-Wahab O ( 2020) SnapShot: Splicing Alterations in Cancer . Cell 180: 208– 208

122 Reber S, Stettler J, Filosa G, Colombo M, Jutzi D, Lenzken SC, Schweingruber C, Bruggmann R, Bachi A, Barabino SM ( 2016) Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants . EMBO J 35: 1504– 1521

123 Rivolta C, McGee TL, Rio Frio T, Jensen RV, Berson EL, Dryja TP ( 2006) Variation in retinitis pigmentosa-11 (PRPF31 or RP11) gene expression between symptomatic and asymptomatic patients with dominant RP11 mutations . Hum Mutat 27: 644– 653

124 Rossbach O, Hung LH, Schreiner S, Grishina I, Heiner M, Hui J, Bindereif A ( 2009) Auto- and cross-regulation of the hnRNP L proteins by alternative splicing . Mol Cell Biol 29: 1442– 1451

125 Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M, Fangazio M, Vaisitti T, Monti S, Chiaretti S ( 2011) Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness . Blood 118: 6904– 6908

126 Ruzickova S, Stanek D ( 2017) Mutations in spliceosomal proteins and retina degeneration . RNA Biol 14: 544– 552

127 Scott LM, Rebel VI ( 2013) Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors . J Natl Cancer Inst 105: 1540– 1549

128 Scotti MM, Swanson MS ( 2016) RNA mis-splicing in disease . Nat Rev Genet 17: 19– 32

129 Sebestyen E, Singh B, Minana B, Pages A, Mateo F, Pujana MA, Valcarcel J, Eyras E ( 2016) Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks . Genome Res 26: 732– 744

130 Shannon JL, Murphy MS, Kantheti U, Burnett JM, Hahn MG, Dorrity TJ, Bacas CJ, Mattice EB, Corpuz KD, Barker BR ( 2018) Polyglutamine binding protein 1 (PQBP1) inhibits innate immune responses to cytosolic DNA . Mol Immunol 99: 182– 190

131 Shi Y ( 2017a) Mechanistic insights into precursor messenger RNA splicing by the spliceosome . Nat Rev Mol Cell Biol 18: 655– 670

132 Shi Y ( 2017b) The spliceosome: a protein-directed metalloribozyme . J Mol Biol 429: 2640– 2653

133 Shirai CL, Ley JN, White BS, Kim S, Tibbitts J, Shao J, Ndonwi M, Wadugu B, Duncavage EJ, Okeyo-Owuor T ( 2015) Mutant U2AF1 expression alters hematopoiesis and pre-mRNA splicing in vivo . Cancer Cell 27: 631– 643

134 Shostak K, Jiang Z, Charloteaux B, Mayer A, Habraken Y, Tharun L, Klein S, Xu X, Duong HQ, Vislovukh A ( 2020) The X-linked trichothiodystrophy-causing gene RNF113A links the spliceosome to cell survival upon DNA damage . Nat Commun 11: 1270

135 Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwilliam R, Ross M, Linehan WM, Birdsall S, Shipley J ( 1996) The t(X;1)(p11.2; q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene . Hum Mol Genet 5: 1333– 1338

136 Singh R, Gupta SC, Peng WX, Zhou N, Pochampally R, Atfi A, Watabe K, Lu Z, Mo YY ( 2016) Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis . Cell Death Dis 7: e2262

137 Singh RK, Cooper TA ( 2012) Pre-mRNA splicing in disease and therapeutics . Trends Mol Med 18: 472– 482

138 Smith MA, Choudhary GS, Pellagatti A, Choi K, Bolanos LC, Bhagat TD, Gordon-Mitchell S, Von Ahrens D Pradhan K, Steeples V, ( 2019) U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies . Nat Cell Biol 21: 640– 650

139 Spitali P, Aartsma-Rus A ( 2012) Splice modulating therapies for human disease . Cell 148: 1085– 1088

140 Staley JP, Woolford JL Jr ( 2009) Assembly of ribosomes and spliceosomes: complex ribonucleoprotein machines . Curr Opin Cell Biol 21: 109– 118

141 Starczynowski DT, Karsan A ( 2010a) Deregulation of innate immune signaling in myelodysplastic syndromes is associated with deletion of chromosome-arm 5q . Cell Cycle 9: 855– 856

142 Starczynowski DT, Karsan A ( 2010b) Innate immune signaling in the myelodysplastic syndromes . Hematol Oncol Clin North Am 24: 343– 359

143 Sureau A, Gattoni R, Dooghe Y, Stevenin J, Soret J ( 2001) SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs . EMBO J 20: 1785– 1796

144 Suzuki H, Kumar SA, Shuai S, Diaz-Navarro A, Gutierrez-Fernandez A, De Antonellis P Cavalli FMG, Juraschka K, Farooq H, Shibahara I, ( 2019) Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma . Nature 574: 707– 711

145 Tanackovic G, Ransijn A, Ayuso C, Harper S, Berson EL, Rivolta C ( 2011a) A missense mutation in PRPF6 causes impairment of pre-mRNA splicing and autosomal-dominant retinitis pigmentosa . Am J Hum Genet 88: 643– 649

146 Tanackovic G, Ransijn A, Thibault P, Abou Elela S, Klinck R, Berson EL, Chabot B, Rivolta C ( 2011b) PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa . Hum Mol Genet 20: 2116– 2130

147 Taylor J, Lee SC ( 2019) Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies . Genes Chro-mosomes Cancer 58: 889– 902

148 Tisdale S, Lotti F, Saieva L, Van Meerbeke JP, Crawford TO, Sumner CJ, Mentis GZ, Pellizzoni L ( 2013) SMN is essential for the biogenesis of U7 small nuclear ribonucleoprotein and 3’-end formation of histone mRNAs . Cell Rep 5: 1187– 1195

149 Tooley M, Lynch D, Bernier F, Parboosingh J, Bhoj E, Zackai E, Calder A, Itasaki N, Wakeling E, Scott R ( 2016) Cerebrocosto-mandibular syndrome: Clinical, radiological, and genetic findings . Am J Med Genet A 170A: 1115– 1126

150 Towns KV, Kipioti A, Long V, McKibbin M, Maubaret C, Vaclavik V, Ehsani P, Springell K, Kamal M, Ramesar RS ( 2010) Prognosis for splicing factor PRPF8 retinitis pigmentosa, novel mutations and correlation between human and yeast phenotypes . Hum Mutat 31: E1361– 1376

151 Tremblay N, Baril M, Chatel-Chaix L, Es-Saad S, Park AY, Koenekoop RK, Lamarre D ( 2016) Spliceosome SNRNP200 promotes viral RNA sensing and IRF3 activation of antiviral response . PLoS Pathog 12: e1005772

152 Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA ( 2010) The nuclearretained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation . Mol Cell 39: 925– 938

153 Turunen JJ, Niemela EH, Verma B, Frilander MJ ( 2013) The significant other: splicing by the minor spliceosome . Wiley Interdiscip Rev RNA 4: 61– 76

154 Turunen JJ, Will CL, Grote M, Luhrmann R, Frilander MJ ( 2008) The U11–48K protein contacts the 5’ splice site of U12-type introns and the U11–59K protein . Mol Cell Biol 28: 3548– 3560

155 Ueno T, Taga Y, Yoshimoto R, Mayeda A, Hattori S, Ogawa-Goto K ( 2019) Component of splicing factor SF3b plays a key role in translational control of polyribosomes on the endoplasmic retic-ulum . Proc Natl Acad Sci U S A 116: 9340– 9349

156 Urbanski LM, Leclair N, Anczukow O ( 2018) Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics . Wiley Interdiscip Rev RNA 9: 1476

157 Venables JP, Brosseau JP, Gadea G, Klinck R, Prinos P, Beaulieu JF, Lapointe E, Durand M, Thibault P, Tremblay K ( 2013) RBFOX2 is an important regulator of mesenchymal tissuespecific splicing in both normal and cancer tissues . Mol Cell Biol 33: 396– 405

158 Verduci L, Simili M, Rizzo M, Mercatanti A, Evangelista M, Mariani L, Rainaldi G, Pitto L( 2010) MicroRNA (miRNA)-mediated interact-tion between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis . J Biol Chem 285: 39551– 39563

159 Verkerk A, Zeidler S, Breedveld G, Overbeek L, Huigh D, Koster L, van der Linde H, de Esch C, Severijnen LA, de Vries BBA ( 2018) CXorf56, a dendritic neuronal protein, identified as a new candidate gene for X-linked intellectual disability . Eur J Hum Genet 26: 552– 560

160 Verma B, Akinyi MV, Norppa AJ, Frilander MJ ( 2018) Minor spliceosome and disease . Semin Cell Dev Biol 79: 103– 112

161 Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A, O’Keefe C, Rogers HJ, Sekeres MA, Maciejewski JP ( 2012a) SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts . Leukemia 26: 542– 545

162 Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, McMahon J, Makishima H, Szpurka H, Jankowska A ( 2012b) SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes . Blood 120: 3173– 3186

163 Vithana EN, Abu-Safieh L, Allen MJ, Carey A, Papaioannou M, Chakarova C, Al-Maghtheh M, Ebenezer ND, Willis C, Moore AT ( 2001) A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11) . Mol Cell 8: 375– 381

164 Wahl MC, Will CL, Luhrmann R ( 2009) The spliceosome: design principles of a dynamic RNP machine . Cell 136: 701– 718

165 Wang GS, Cooper TA ( 2007) Splicing in disease: disruption of the splicing code and the decoding machinery . Nat Rev Genet 8: 749– 761

166 Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K, Werner L, Sivachenko A, DeLuca DS, Zhang L ( 2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia . N Engl J Med 365: 2497– 2506

167 Wassarman DA, Steitz JA ( 1992) Interactions of small nuclear RNA’s with precursor messenger RNA during in vitro splicing . Science 257: 1918– 1925

168 Watanabe H, Shionyu M, Kimura T, Kimata K, Watanabe H ( 2007) Splicing factor 3b subunit 4 binds BMPR-IA and inhibits osteo-chondral cell differentiation . J Biol Chem 282: 20728– 20738

169 Waterfall JJ, Arons E, Walker RL, Pineda M, Roth L, Killian JK, Abaan OD, Davis SR, Kreitman RJ, Meltzer PS ( 2014) High prevalence of MAP2K1 mutations in variant and IGHV4-34- expressing hairy-cell leukemias . Nat Genet 46: 8– 10

170 Wieczorek D, Gener B, Gonzalez MJ, Seland S, Fischer S, Hehr U, Kuechler A, Hoefsloot LH, de Leeuw N, Gillessen-Kaesbach G ( 2009) Microcephaly, microtia, preauricular tags, choanal atresia and developmental delay in three unrelated patients: a mandibulofacial dysostosis distinct from Treacher Collins syn-drome . Am J Med Genet A 149A: 837– 843

171 Wieczorek D, Newman WG, Wieland T, Berulava T, Kaffe M, Falkenstein D, Beetz C, Graf E, Schwarzmayr T, Douzgou S ( 2014) Compound heterozygosity of low-frequency promoter deletions and rare loss-of-function mutations in TXNL4A causes Burn-McKeown syndrome . Am J Hum Genet 95: 698– 707

172 Will CL, Luhrmann R ( 2011) Spliceosome structure and function . Cold Spring Harb Perspect Biol 3: a003707

173 Will CL, Luhrmann R ( 2006) Spliceosome structure and function. In The RNA World, Gesteland RF et al, eds. (Cold Spring Harbor, New York, Cold Spring Harbor Laboratory Press), pp. 369– 400

174 Wu S, Romfo CM, Nilsen TW, Green MR ( 1999) Functional recognition of the 3’ splice site AG by the splicing factor U2AF35 . Nature 402: 832– 835

175 Xiong F, Liu HH, Duan CY, Zhang BK, Wei G, Zhang Y, Li S ( 2019) Arabidopsis JANUS Regulates Embryonic Pattern Formation through Pol II-Mediated Transcription of WOX2 and PIN7 . iScience 19: 1179– 1188

176 Xu M, Xie YA, Abouzeid H, Gordon CT, Fiorentino A, Sun Z, Lehman A, Osman IS, Dharmat R, Riveiro-Alvarez R ( 2017) Mutations in the spliceosome component CWC27 cause retinal degeneration with or without additional developmental anoma-lies . Am J Hum Genet 100: 592– 604

177 Yip BH, Dolatshad H, Roy S, Pellagatti A, Boultwood J ( 2016) Impact of splicing factor mutations on pre-mrna splicing in the myelodysplastic syndromes . Curr Pharm Des 22: 2333– 2344

178 Yoh SM, Schneider M, Seifried J, Soonthornvacharin S, Akleh RE, Olivieri KC, De Jesus PD Ruan C, de Castro E, Ruiz PA, ( 2015) PQBP1 Is a proximal sensor of the cGAS-dependent innate response to HIV-1 . Cell 161: 1293– 1305

179 Yoshida K, Ogawa S ( 2014) Splicing factor mutations and cancer . Wiley Interdiscip Rev RNA 5: 445– 459

180 Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M ( 2011) Frequent pathway mutations of splicing machinery in myelodysplasia . Nature 478: 64– 69

181 Yoshida T, Kim JH, Carver K, Su Y, Weremowicz S, Mulvey L, Yamamoto S, Brennan C, Mei S, Long H ( 2015) CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer . Cancer Res 75: 1516– 1526

182 Zhang D, Hu Q, Liu X, Ji Y, Chao HP, Liu Y, Tracz A, Kirk J, Buonamici S, Zhu P ( 2020) Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer . Nat Commun 11: 2089

183 Zhang D, Yue T, Choi JH, Nair-Gill E, Zhong X, Wang KW, Zhan X, Li X, Choi M, Tang M ( 2019) Syndromic immune disorder caused by a viable hypomorphic allele of spliceosome compo-nent Snrnp40 . Nat Immunol 20: 1322– 1334

184 Zhang J, Lieu YK, Ali AM, Penson A, Reggio KS, Rabadan R, Raza A, Mukherjee S, Manley JL ( 2015) Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities . Proc Natl Acad Sci U S A 112: E4726– 4734

185 Zhang J, Manley JL ( 2013) Misregulation of pre-mRNA alternative splicing in cancer . Cancer Discov 3: 1228– 1237

186 Zhang S, Wei JS, Li SQ, Badgett TC, Song YK, Agarwal S, Coarfa C, Tolman C, Hurd L, Liao H ( 2016a) MYCN controls an alternative RNA splicing program in high-risk metastatic neurob-lastoma . Cancer Lett 371: 214– 224

187 Zhang SJ, Rampal R, Manshouri T, Patel J, Mensah N, Kayserian A, Hricik T, Heguy A, Hedvat C, Gonen M ( 2012) Genetic analysis of patients with leukemic transformation of myeloprolif-erative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome . Blood 119: 4480– 4485

188 Zhang Z, Zhou N, Huang J, Ho TT, Zhu Z, Qiu Z, Zhou X, Bai C, Wu F, Xu M ( 2016b) Regulation of androgen receptor splice variant AR3 by PCGEM1 . Oncotarget 7: 15481– 15491

189 Zhao C, Lu S, Zhou X, Zhang X, Zhao K, Larsson C ( 2006) A novel locus (RP33) for autosomal dominant retinitis pigmentosa mapping to chromosomal region 2cen-q12.1 . Hum Genet 119: 617– 623

190 Zhong XY, Ding JH, Adams JA, Ghosh G, Fu XD ( 2009) Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones . Genes Dev 23: 482– 495

191 Zhou Z, Qiu J, Liu W, Zhou Y, Plocinik RM, Li H, Hu Q, Ghosh G, Adams JA, Rosenfeld MG ( 2012) The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus . Mol Cell 47: 422– 433